| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |